Antifungal pulled over hepatotoxicity fears

The oral antifungal ketoconazole is being taken off the market in Australia amid concern about potentially fatal liver injury.

Drug manufacturer Janssen-Cilag is deregistering oral ketoconazle (Nizoral) 200mg tablets and ceasing supply from 1 December, the Therapeutic Goods Administration announced.

There have been several warnings about the medication's safety profile in recent months.

In July, the European Medicines Agency recommended oral ketoconazole be